Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Leverger

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Haematologica|May 15, 2012
Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocolVirginie Gandemer, Sylvie Chevret, Arnaud Petit, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
BMC Cancer|January 16, 2009
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 studyVirginie Gandemer, Marie-Francoise Auclerc, Yves Perel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemiaHélène Lapillonne, Aline Renneville, Anne Auvrignon, et al.
Haematologica|January 25, 2015
Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. programVincent Barlogis, Pascal Auquier, Yves Bertrand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL GroupCecile Bally, Jehane Fadlallah, Guy Leverger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 studyCaroline Oudot, Marie-Françoise Auclerc, Vincent Levy, et al.
Blood|June 29, 2014
Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocationsJean-Baptiste Micol, Nicolas Duployez, Nicolas Boissel, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Haematologica|May 15, 2012
Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocolVirginie Gandemer, Sylvie Chevret, Arnaud Petit, et al.
Blood|April 26, 2018
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaRaphael Itzykson, Nicolas Duployez, Annette Fasan, et al.
BMC Cancer|January 16, 2009
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 studyVirginie Gandemer, Marie-Francoise Auclerc, Yves Perel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemiaHélène Lapillonne, Aline Renneville, Anne Auvrignon, et al.
Haematologica|January 25, 2015
Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. programVincent Barlogis, Pascal Auquier, Yves Bertrand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL GroupCecile Bally, Jehane Fadlallah, Guy Leverger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 studyCaroline Oudot, Marie-Françoise Auclerc, Vincent Levy, et al.
Blood|June 29, 2014
Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocationsJean-Baptiste Micol, Nicolas Duployez, Nicolas Boissel, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Pageof 20